OEM

EverBio Technology Inc.

6F-7, No. 7, Wuquan 1st Rd., Xinzhuang District , 23456 New Taipei City
Taiwan

Telephone +886 2 22981260
Fax +886 2 22981263
info@everbiotech.com

This company is co-exhibitor of
TAITRA Taiwan External Trade Development Council

Trade fair hall

  • Hall 17 / A61
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 17): stand A61

Fairground map

MEDICA 2016 fairground map: Hall 17

Our range of products

Product categories

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.06  Haematology reagents

Haematology reagents

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.06  Haematology reagents
  • 03.03.06.01  Devices for histology

Devices for histology

Our products

Product category: Devices for histology

Tissue Micro Arrayer

Analyzing Tissue from Clinical Practice to Medical Research

As the US President Obama unveiled the Precision Medicine Initiative (PMI), we must gain insights into the individual variability in genes as well as the subtypes of diseases based on the molecular and cellular analysis.

Technologies such as DNA microarrays allow researchers to examine the changes in the genome (DNA), transcription (mRNA), proteome (proteins), or metabolome (metabolites) in order to understand the physiology and mechanism of disease. In particular, the application of DNA microarray has led to the comprehension of the molecular and pathophysiological characteristics of an individual patient and tumor. However, the large volumes of data produced by DNA microarrays require further validation, which can be both time-consuming and expensive. Tissue microarrays (TMAs) have become the predominant clinical research tool for validation tools from DNA microarray-based gene expression profiling as it can mimic the real-world clinical samples by treating hundreds of tissues as one sample.
As DNA microarrays and TMAs provide deeper understanding of cancer biology and uncover new sub-classifications of cancer and likely patient responses - all of which influence new courses of treatment and future drug design. The TMA techniques have been in use for 15 years since the tool was first fabricated in 1998 and resulted in more than 20-fold increase in the amount of papers published in academic journal this year.

More Less

About us

Company details


Specializing in automate equipment in all fields of Biotechnology, covering Cell and Molecular Biology, Pathology, Microbiology, Immunology, Clinical Research and etc. With our previous accumulated abundant experiences in developing automate equipment in semi conductor field.

Our Mission
EverBio pursue to develop affordable as well as reliable bio-medical products for clinical research and diagnosis. Our technology not only improves and simplifies the research methods, also boost the procedure in fast and easy way.

Our Vision
In the future we will continuously make effort to research and development and contribute positively to the lab automation industry by offering complete customer satisfaction with our commitment to the best in product quality and durability.

"Medical research through advancing Innovative Workflow and Imaging Mining."

More Less

Company data

Area of business
  • Electromedical equipment / Medical Technology
  • Laboratory Equipment